Ignite Creation Date:
2024-05-05 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00143975
Status:
COMPLETED
Last Update Posted:
2010-08-12
First Post:
2005-08-31
Brief Title:
Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML GO-A-HAM
Sponsor:
University of Ulm
Organization:
University of Ulm
Organization Data
Organization:
University of Ulm
Class:
OTHER
Study ID:
AMLSG05-04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Ulm
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Prof Dr Reinhard Marre
Old Organization:
University of Ulm